Analyst Charles Duncan raised his target to $25
https://www.streetinsider.com/Analyst+Comments/Anavex+Life+Sciences+%28AVXL%29+PT+Raised+to+Street+High+%2425+at+Cantor+Fitzgerald/18020535.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.